December 31, 2020 3

“After a number of strict reviews, verification, test and marketing information analysis in accordance with the law and procedures, without a doubt concluded that the known and likely benefits of Sinopharm’s new inactivated coronavirus vaccine are bigger than the famous and potential risks, and it over all meets the pre-set requirements attached to conditional marketing standards, ” that she said.…

This news comes via ChinaPulse.com, which delivers news, data, analysis, and insights on Chinese business, travel, finance, health, military, investment, and technology.